Sacroiliac sprain
Methodology & AI Transparency ⓘ
Sacroiliac sprain Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Sacroiliac sprain—coded clinically as S33.6XXA across Back, Spine & Ortho guidelines—combines targeted anti-inflammatory or in Sacroiliac sprain (S33.6XXA: epidural interventions) with structured follow-up of 25-Hydroxy Vitamin D [Sacroiliac sprain S33.6XXA] (40 – 65 ng/mL (S33.6XXA)).
- 2 Real-world patient consensus: Diagnostic registry S33.6XXA: Sacroiliac sprain is managed within Back, Spine & Ortho.
- 3 Typical cash cost range: Workup highlights for Sacroiliac sprain (S33.6XXA): targeted anti-inflammatory or in Sacroiliac sprain (S33.6XXA: epidural interventions).
- 4 Top reported side effects / signs: Key Back, Spine & Ortho biomarkers for Sacroiliac sprain (S33.6XXA): Oswestry / Functional in Sacroiliac sprain (S33.6XXA: Mobility Score) & 25-Hydroxy Vitamin D [Sacroiliac sprain S33.6XXA] (40 – 65 ng/mL (S33.6XXA)).
Ask our AI Specialists anything about Sacroiliac sprain
What Is Sacroiliac sprain?
Sacroiliac sprain—coded clinically as S33.6XXA across Back, Spine & Ortho guidelines—combines targeted anti-inflammatory or in Sacroiliac sprain (S33.6XXA: epidural interventions) with structured follow-up of 25-Hydroxy Vitamin D [Sacroiliac sprain S33.6XXA] (40 – 65 ng/mL (S33.6XXA)).
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Sacroiliac sprain (S33.6XXA, Back, Spine & Ortho) reflects mechanical [Sacroiliac sprain S33.6XXA]. longitudinal control is benchmarked via Oswestry / Functional in Sacroiliac sprain (S33.6XXA: Mobility Score).
Common Symptoms & Clinical Signs
- • Presentation of Sacroiliac sprain (S33.6XXA): sharp radicular pain in Sacroiliac sprain (S33.6XXA: shooting down the)
- • Secondary Sacroiliac sprain clinical sign: paraspinal muscle spasm, in Sacroiliac sprain (S33.6XXA: guarded posture, or)
- • Symptom flares in Sacroiliac sprain correlating with Oswestry / Functional in Sacroiliac sprain (S33.6XXA: Mobility Score) deviation outside Minimal functional limitation (S33.6XXA)
- • Functional back, spine & ortho impact requiring targeted anti-inflammatory or in Sacroiliac sprain (S33.6XXA: epidural interventions) evaluation (S33.6XXA)
Sacroiliac sprain Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | S33.6XXA | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Back Pain, Spine & Musculoskeletal Injuries | NLM Clinical Tables |
| Diagnostic / Lab Marker: Oswestry / Functional in Sacroiliac sprain (S33.6XXA: Mobility Score) | Minimal functional limitation (S33.6XXA) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D [Sacroiliac sprain S33.6XXA] | 40 – 65 ng/mL (S33.6XXA) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Neurologic Myotome / in Sacroiliac sprain (S33.6XXA: Reflex Exam) | 5/5 symmetrical motor strength (S33.6XXA) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Sacroiliac sprain
Treatment selection for Sacroiliac sprain depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Sacroiliac sprain)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Established ASAS definition and preliminary proposed data-driven cut-offs for The purpose of this paper is to evaluate patient characteristics and treatment outcomes in patients with nonradiographic axial spondyloarthritis (nr-axSpA) eligible for a clinical trial based on the 2009 established Assessment... Annals of the rheumatic diseases • 2026-09-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 42350183 ↗ |
| Can This Approach Help? Inside the Latest Research on Romosozumab efficacy on fracture outcomes is greater in patients at high baseline Efficacy of romosozumab on clinical fracture, osteoporotic fracture, and MOF is significantly greater in patients at high baseline fracture risk compared with placebo. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA • 2021-08-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33537844 ↗ |
| Can This Approach Help? Inside the Latest Research on Established and preliminarily proposed ASAS MRI working group cut-offs for This analysis suggests that the preliminary 2021 cut-offs for MRI inflammatory lesions may slightly increase the specificity of the quantitative part of the 2009 MRI inflammatory lesion definition. RMD open • 2024-09-03 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 39231546 ↗ |
Sacroiliac sprain Patient Community & “People Like Me” Threads
Filter Sacroiliac sprain community threads and patient logs by age, biological sex, dosage, and treatment duration.